Mount Yale Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-400
Closed -$68K 901
2018
Q3
$68K Sell
400
-75
-16% -$13.8K 0.01% 552
2018
Q2
$79K Buy
475
+75
+19% +$12K 0.02% 533
2018
Q1
$67K Buy
+400
New +$67.1K 0.01% 562

Other funds holding AGN

Mount Yale Investment Advisors's AGN Position: Q4 2018 in Review

Mount Yale Investment Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 400 shares — an estimated $68K sold.

Mount Yale Investment Advisors first reported a position in AGN in Q1 2018 and held it in 3 quarters. The position peaked at $79K in Q2 2018. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Mount Yale Investment Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Mount Yale Investment Advisors sold 400 Allergan plc shares in Q4 2018, an estimated $68K.
  • Mount Yale Investment Advisors first reported a position in Allergan plc in Q1 2018 and held it in 3 quarters.
  • Mount Yale Investment Advisors's Allergan plc position peaked at $79K in Q2 2018.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Mount Yale Investment Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.